Skip to main content

Table 1 Minimal inhibitory concentrations (MIC; μg/mL) of tested agents against clinical strains of Escherichia coli from patients diagnosed with recurrent urinary tract infections

From: Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications

Strains

AMP

LL-37

CSA-13

CSA-131

LL-37 + AMP

LL-37 + CSA-13

LL-37 + CSA-131

E. coli

4

64

2

16

4

2

1

E. coli

4

64

4

8

4

2

2

E. coli

4

64

4

16

4

2

2

E. coli

4

32

4

16

4

0.25

2

E. coli

4

64

2

16

4

2

2

  1. AMP, ampicillin; E. coli, clinical isolate of Escherichia coli
Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us